Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$324M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$281M |
| 4 |
DuPont de Nemours
DD
|
+$278M |
| 5 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
Johnson & Johnson
JNJ
|
+$281M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$205M |
| 4 |
Bausch Health
BHC
|
+$183M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.85% |
| 2 | Technology | 3.93% |
| 3 | Financials | 3.3% |
| 4 | Energy | 3.26% |
| 5 | Communication Services | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Erie Indemnity
ERIE
$13.2B
| $609K | ﹤0.01% |
7,424
+1,851
| +33% | +$154K |
|
3127
Essent Group
ESNT
$6.33B
| $607K | ﹤0.01% |
25,308
+7,574
| +43% | +$208K |
|
|
EXAS
3128
PUT
DELISTED
Exact Sciences
EXAS
| $607K | ﹤0.01% |
35,700
-2,500
| -7% | -$57.4K |
|
3129
CALL
Synaptics
SYNA
$4.15B
| $607K | ﹤0.01% |
7,400
-7,000
| -49% | -$529K |
|
3130
Argan
AGX
$8.37B
| $605K | ﹤0.01% |
17,790
+17,543
| +7,102% | +$675K |
|
3131
Coherent
COHR
$74.2B
| $605K | ﹤0.01% |
37,876
+34,112
| +906% | +$588K |
|
|
YDKG
3132
Yueda Digital Holding
YDKG
$5.97M
| $602K | ﹤0.01% |
+60
| New | +$565K |
|
3133
Jakks Pacific
JAKK
$293M
| $602K | ﹤0.01% |
7,520
+6,543
| +670% | +$615K |
|
|
SAVE
3134
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $602K | ﹤0.01% |
12,800
+2,500
| +24% | +$140K |
|
|
CBD
3135
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $602K | ﹤0.01% |
50,208
| – | – |
|
|
CIE
3136
PUT
DELISTED
Cobalt International Energy, Inc
CIE
| $602K | ﹤0.01% |
5,733
-260
| -4% | -$31.6K |
|
3137
NNN REIT
NNN
$8.99B
| $601K | ﹤0.01% |
16,711
-35,795
| -68% | -$1.3M |
|
|
MWE
3138
PUT
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $601K | ﹤0.01% |
14,300
-15,000
| -51% | -$855K |
|
3139
Green Plains
GPRE
$1.03B
| $600K | ﹤0.01% |
31,503
+13,410
| +74% | +$296K |
|
3140
G-III Apparel Group
GIII
$1.5B
| $599K | ﹤0.01% |
9,804
-4,558
| -32% | -$313K |
|
3141
Silgan Holdings
SLGN
$4.41B
| $599K | ﹤0.01% |
23,010
-3,694
| -14% | -$97.5K |
|
3142
Broadridge
BR
$19B
| $598K | ﹤0.01% |
10,877
-37,388
| -77% | -$2.01M |
|
3143
Pilgrim's Pride
PPC
$6.54B
| $598K | ﹤0.01% |
29,971
-78,614
| -72% | -$1.69M |
|
3144
VEON
VEON
$3.95B
| $598K | ﹤0.01% |
5,986
-4,748
| -44% | -$593K |
|
3145
Franco-Nevada
FNV
$46B
| $597K | ﹤0.01% |
+13,560
| New | +$584K |
|
|
MWW
3146
DELISTED
Monster Worldwide Inc
MWW
| $597K | ﹤0.01% |
99,538
+21,634
| +28% | +$147K |
|
3147
CALL
ProShares Ultra Technology
ROM
$1.29B
| $596K | ﹤0.01% |
142,400
+110,400
| +345% | +$508K |
|
3148
CALL
Sempra
SRE
$54.8B
| $595K | ﹤0.01% |
12,400
+7,800
| +170% | +$384K |
|
|
KATE
3149
PUT
DELISTED
Kate Spade & Company
KATE
| $595K | ﹤0.01% |
31,300
-6,000
| -16% | -$120K |
|
3150
PUT
Core Laboratories
CLB
$521M
| $594K | ﹤0.01% |
6,000
-16,300
| -73% | -$1.77M |
|
Similar funds
Barclays's Q3 2015 Portfolio in Review
As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.
- Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
- Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
- Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
- Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
- Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
- Barclays opened 382 new positions and closed 515 in Q3 2015.
- Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.
Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.